These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 3717228)

  • 1. Estrogen use and cardiovascular disease.
    Henderson BE; Ross RK; Paganini-Hill A; Mack TM
    Am J Obstet Gynecol; 1986 Jun; 154(6):1181-6. PubMed ID: 3717228
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estrogen use and cardiovascular disease.
    Henderson BE; Ross RK; Paganini-Hill A
    J Reprod Med; 1985 Oct; 30(10 Suppl):814-20. PubMed ID: 4078814
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Postmenopausal estrogen therapy and cardiovascular disease. Ten-year follow-up from the nurses' health study.
    Stampfer MJ; Colditz GA; Willett WC; Manson JE; Rosner B; Speizer FE; Hennekens CH
    N Engl J Med; 1991 Sep; 325(11):756-62. PubMed ID: 1870648
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Postmenopausal estrogen use and mortality. Results from a prospective study in a defined, homogeneous community.
    Criqui MH; Suarez L; Barrett-Connor E; McPhillips J; Wingard DL; Garland C
    Am J Epidemiol; 1988 Sep; 128(3):606-14. PubMed ID: 3414664
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estrogen replacement therapy and protection from acute myocardial infarction.
    Henderson BE; Paganini-Hill A; Ross RK
    Am J Obstet Gynecol; 1988 Aug; 159(2):312-7. PubMed ID: 3251473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hormone replacement therapy and secondary cardiovascular prevention: a meta-analysis of randomized trials.
    Cho L; Mukherjee D
    Cardiology; 2005; 104(3):143-7. PubMed ID: 16118493
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progestogens in cardiovascular diseases: an introduction to the epidemiologic data.
    Mann JI
    Am J Obstet Gynecol; 1982 Mar; 142(6 Pt 2):752-7. PubMed ID: 7065056
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estrogen replacement therapy and vascular disease: the Leisure World Study.
    Paganini-Hill A
    Postgrad Med; 1989 Apr; Spec No():49-50; discussion 89-90. PubMed ID: 2726625
    [No Abstract]   [Full Text] [Related]  

  • 9. Decreased mortality in users of estrogen replacement therapy.
    Henderson BE; Paganini-Hill A; Ross RK
    Arch Intern Med; 1991 Jan; 151(1):75-8. PubMed ID: 1985611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estrogen replacement therapy in the elderly.
    Paganini-Hill A
    Zentralbl Gynakol; 1996; 118(5):255-61. PubMed ID: 8701621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estrogen replacement and cardiovascular disease: serum lipids and blood pressure effects.
    Hazzard WR
    Am J Obstet Gynecol; 1989 Dec; 161(6 Pt 2):1847-53. PubMed ID: 2690637
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heart disease risk factors and hormone use in postmenopausal women.
    Barrett-Connor E; Brown WV; Turner J; Austin M; Criqui MH
    JAMA; 1979 May; 241(20):2167-9. PubMed ID: 430817
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaginal estradiol use and the risk for cardiovascular mortality.
    Mikkola TS; Tuomikoski P; Lyytinen H; Korhonen P; Hoti F; Vattulainen P; Gissler M; Ylikorkala O
    Hum Reprod; 2016 Apr; 31(4):804-9. PubMed ID: 26874358
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiovascular and cancer morbidity and mortality and sudden cardiac death in postmenopausal women on oestrogen replacement therapy (ERT).
    Sourander L; Rajala T; Räihä I; Mäkinen J; Erkkola R; Helenius H
    Lancet; 1998 Dec 19-26; 352(9145):1965-9. PubMed ID: 9872245
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Estrogens and cardiovascular risk in postmenopausal women. I. Epidemiologic data].
    Sitruk-Ware R
    Presse Med; 1990 Jun; 19(26):1230-5. PubMed ID: 2142774
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Postmenopausal estrogen use, cigarette smoking, and cardiovascular morbidity in women over 50. The Framingham Study.
    Wilson PW; Garrison RJ; Castelli WP
    N Engl J Med; 1985 Oct; 313(17):1038-43. PubMed ID: 2995808
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of body mass on the association between estrogen replacement therapy and mortality among elderly US women.
    Rodriguez C; Calle EE; Patel AV; Tatham LM; Jacobs EJ; Thun MJ
    Am J Epidemiol; 2001 Jan; 153(2):145-52. PubMed ID: 11159159
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative cardiovascular effects of different progestins in menopause.
    Rosano GM; Fini M
    Int J Fertil Womens Med; 2001; 46(5):248-56. PubMed ID: 11720197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Noncontraceptive estrogen use and cardiovascular disease.
    Bush TL; Barrett-Connor E
    Epidemiol Rev; 1985; 7():89-104. PubMed ID: 2996919
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Postmenopausal estrogen and progestin use and the risk of cardiovascular disease.
    Grodstein F; Stampfer MJ; Manson JE; Colditz GA; Willett WC; Rosner B; Speizer FE; Hennekens CH
    N Engl J Med; 1996 Aug; 335(7):453-61. PubMed ID: 8672166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.